Transplantation Conditioning

Before a transplant, doctors often give the patient special treatments. These treatments help prepare the body for the new tissue or organ. They might use medicine, radiation, or other therapies to make the body accept the transplant.

Procedure

What people who've had Transplantation Conditioning report

Every report comes from a Lived member, sent anonymously.

NameHow it went

No reports yet

Add what worked for you with the search bar below

About Transplantation Conditioning

Who It's For

Transplantation conditioning is the intensive treatment given in the days before a blood stem cell transplant, often called a bone marrow transplant. It usually consists of high-dose chemotherapy, sometimes combined with radiation to the whole body. Conditioning has two jobs: to clear out diseased or cancerous cells in the bone marrow, and to suppress the immune system so it does not attack the new stem cells. Without that preparation, transplanted cells from a donor would usually be rejected, and in cancer the disease would remain. Conditioning is part of transplants for blood cancers such as leukemia, lymphoma, multiple myeloma and myelodysplastic syndromes, as well as some other cancers. It is also used before transplants for noncancerous conditions such as aplastic anemia, sickle cell disease, thalassemia and certain immune deficiencies, and before gene therapies for sickle cell disease and thalassemia that return a person's own modified stem cells. In an autologous transplant, a person's own stem cells are collected and frozen first, so very high doses can be given to kill cancer and the stored cells are then returned to restore the marrow. In an allogeneic transplant, the cells come from a donor. Regimens differ mainly in intensity. Myeloablative conditioning uses doses strong enough to destroy the remaining marrow. Reduced-intensity conditioning, sometimes called a mini transplant, uses lower doses that weaken the immune system enough for donor cells to take hold and then rely partly on those donor cells to attack remaining cancer. Lower intensity makes transplant possible for many older people and people with other health problems. In trials of adults with acute myeloid leukemia or myelodysplastic syndromes, it caused fewer treatment-related deaths and less graft-versus-host disease, though stronger conditioning tended to work better for high-risk disease. The transplant team chooses the regimen based on the disease, its stage, the donor, age and overall health.

Before the Procedure

Preparation usually takes several weeks. The team reviews the medical history, does a physical exam and runs many tests, including checks of how well the heart, lungs, kidneys and liver are working, to judge whether the body can tolerate the planned regimen. A central venous catheter, a thin tube placed into a large vein in the chest, neck or arm, is usually inserted before treatment starts. It is used to give chemotherapy, fluids, blood products and nutrition, and to draw blood without repeated needle sticks. Conditioning can permanently affect fertility and can bring on early menopause, particularly with total body irradiation or busulfan, a chemotherapy drug commonly used in these regimens. Anyone who may want biological children should ask about freezing eggs, sperm or embryos before conditioning begins, because there is usually no chance to do it afterward. Pregnancy must be ruled out, and the team should know about every medicine and supplement being taken. The practical arrangements matter almost as much as the medical ones. Most people need someone to help with daily tasks for weeks after the transplant, and people who live far away may need housing near the hospital. It helps to arrange medical leave, childcare, pet care, bill payments and insurance approval in advance, and to complete an advance directive.

During the Procedure

Conditioning usually lasts about a week or two, depending on the regimen. Chemotherapy is given through the central line, sometimes alongside pills, often in the hospital and sometimes in an outpatient transplant clinic. If total body irradiation is part of the plan, it is delivered in short sessions, sometimes twice a day over several days; the radiation itself is painless. The day the new stem cells are infused, through the central line much like a blood transfusion, is often called day zero. There are often a few days of rest between the last conditioning dose and day zero. Throughout, the team gives anti-nausea medicine and other supportive drugs and checks blood tests closely. Nausea, vomiting, tiredness and loss of appetite often begin during these days.

Recovery & Aftercare

The effects of conditioning peak in the week or two after the transplant. Blood counts fall to very low levels, which leaves a person highly vulnerable to infection and bleeding until the new stem cells settle in the marrow and begin producing blood cells, a step called engraftment. Most people need blood transfusions during this period and receive antibiotic, antifungal and antiviral medicines. Mouth and throat sores (mucositis) are common and can be painful enough to require strong pain medicine and, for a while, nutrition through the vein. Hair loss, diarrhea and deep fatigue are also typical. How long this lasts varies. Many people stay in the hospital or near the center for several weeks, and after an allogeneic transplant people commonly remain close for about the first 100 days, with clinic visits two or three times a week. Blood counts may recover within a few weeks, but the immune system takes much longer: several months after an autologous transplant and one to two years after an allogeneic one. During that time, centers give detailed rules about hand hygiene, safe eating and drinking water, crowds and contact with sick people. Full recovery of energy commonly takes up to a year. Fever, chills, shaking or feeling suddenly unwell while counts are low can signal a serious infection and need a call to the transplant team right away, using the 24-hour number the center provides. New bleeding or easy bruising, mouth sores that make it hard to eat or drink, severe diarrhea or trouble breathing also need prompt contact with the team.

Risks & Complications

Conditioning is one of the main reasons stem cell transplant is a serious undertaking, and its complications can be life-threatening. The most immediate dangers come from the period of very low blood counts: infections that can become severe quickly and bleeding. Other early complications include severe mucositis, kidney strain, and a liver problem in which the small veins of the liver become blocked (sinusoidal obstruction syndrome, also called veno-occlusive disease). Sometimes the new cells fail to grow, called graft failure. In allogeneic transplants, conditioning also sets the stage for graft-versus-host disease, in which donor immune cells attack the recipient's skin, liver, gut or other organs; in trials, reduced-intensity regimens caused less of it. Later effects can appear months or years afterward. They include infertility and early menopause, cataracts, bone and muscle weakness, damage to the lungs, heart, liver or kidneys, and a higher risk of a second cancer. In children, growth can be affected. Higher intensity and total body irradiation generally carry more of these risks, while lower intensity can leave a higher chance of relapse in some cancers. How these trade-offs balance depends on age, overall health, the disease and its stage, and the type of transplant, which is why the regimen is tailored to each person and why long-term follow-up with doctors experienced in transplant care matters.

Questions to Ask Your Doctor

  1. 1.Which conditioning regimen do you recommend for me, and why that intensity rather than a stronger or milder one?
  2. 2.Will my regimen include total body irradiation or busulfan, and what can I do to preserve fertility before it starts?
  3. 3.What side effects should I expect during conditioning and the first weeks after transplant, and how will you manage them?
  4. 4.How long will I need to stay in the hospital or near the center, and what will my caregiver need to do?
  5. 5.Which long-term effects of this regimen should I be monitored for, and who will do that follow-up?

Last reviewed • Oct 2026

Educational content, not medical advice.